Pharmaceutical News

RSS

Researchers find HPV vaccination disparities among low-income females

Researchers at Moffitt Cancer Center and colleagues at the University of Florida studied health care providers to determine the factors associated with disparities in Human Papillomavirus (HPV) vaccination among girls, ages 9 to 17, from low-income families.

27 Mar 2013

Viewpoints: Rising cost of Tricare; GOP needs to better explain Medicare eligibility age issue; Don't forget adult immunizations

The U.S. government's fiscal predicament has many causes. But if you had to reduce them to one sentence, it might go like this: "Congress responds to the short-term demands of particular groups, not the long-term needs of the nation as a whole."

27 Mar 2013

Questions from High Court suggest concerns about 'pay-for-delay' deals

The Supreme Court heard arguments yesterday in a case which pits brand name and generic drug manufacturers against the Federal Trade Commission.

27 Mar 2013

Lundbeck, Otsuka reach agreement to develop and commercialize Lu AE58054

H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. today announced a license and development agreement for Lu AE58054, a selective 5HT6 receptor antagonist currently in development for the treatment of Alzheimer's disease.

26 Mar 2013

Clinigen announces acquisition of Cardioxane from Novartis

Clinigen Group plc today announced the acquisition of Cardioxane (dexrazoxane) from Novartis for US$33 million in cash, payable in two tranches.

From Clinigen Group 26 Mar 2013

New vaccine proves highly effective against H5N1 virus

Until now most experimental vaccines against the highly lethal H5N1 avian influenza virus have lacked effectiveness. But a new vaccine has proven highly effective against the virus when tested in both mice and ferrets. It is also effective against the H9 subtype of avian influenza.

26 Mar 2013

Experts to meet in Cape Town to discuss development of vaccines for deadly airborne disease

At a time of growing global concern about the rising level of drug-resistant strains of tuberculosis in South Africa and worldwide, the world's top TB vaccine experts are meeting this week, the first time this scientific forum has been held in Africa, where they will present new research aimed at advancing development of vaccines against the deadly airborne disease.

26 Mar 2013

Supreme Court to hear case about 'pay to delay' deals between generic and branded drug makers

Generic and the brand-name drug companies -- usually fierce competitors -- will be on the same side as they argue their case against the federal government.

26 Mar 2013

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

VIVUS, Inc. announced today that a new study demonstrates that effective medical treatment providing 10% to 15% weight loss could lead to significant improvements in Medicare spending by reversing or reducing significant health consequences such as type 2 diabetes, hypertension and dyslipidemia in obese or overweight patients.

25 Mar 2013

arGEN-X advances ARGX-112 into formal preclinical development

arGEN-X, a clinical stage biopharmaceutical company specialized in the discovery and development of highly differentiated human monoclonal antibody therapeutics, announces that it has progressed ARGX-112, its fourth therapeutic candidate, into formal preclinical development.

25 Mar 2013

Scientists develop new chemo drug that fights cancer without impacting fertility

A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine- scientists to be less toxic to a young woman's fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.

25 Mar 2013

Japan's MHLW approves XELJANZ for treatment of adults with rheumatoid arthritis

Pfizer Inc. announced today that the Japanese Ministry of Health, Labor and Welfare has approved XELJANZ (tofacitinib citrate) for the treatment of adults with rheumatoid arthritis who have had an inadequate response to existing therapies.

25 Mar 2013

First Edition: March 25, 2013

Today's headlines include reports about the continuing outlook for progress on the federal budget as well as a variety of stories related to the health law's implementation.

25 Mar 2013

Actavis settles patent litigation with AstraZeneca over generic version of Crestor

Actavis, Inc., a leading specialty pharmaceutical company, today announced that is has reached a settlement agreement with AstraZeneca resolving outstanding patent litigation related to Actavis' generic version of rosuvastatin calcium 5, 10, 20 and 40 mg tablets, the generic version of Crestor tablets, as well as Actavis' rosuvastatin zinc alternate salt product.

25 Mar 2013

Study shows why certain drugs that interact with serotonin receptors have harmful effects

A team including scientists from The Scripps Research Institute (TSRI), the University of North Carolina at Chapel Hill and the Chinese Academy of Sciences has determined and analyzed the high-resolution atomic structures of two kinds of human serotonin receptor.

25 Mar 2013

Anti-inflammatory drug naproxen may exhibit antiviral activity against influenza A virus

The over-the-counter anti-inflammatory drug naproxen may also exhibit antiviral activity against influenza A virus, according to a team of French scientists. The finding, the result of a structure-based investigation, is published online ahead of print in the journal Antimicrobial Agents and Chemotherapy.

25 Mar 2013

Parkinson's Disease drug can help reverse age-related impairments in decision making: Study

A drug widely used to treat Parkinson's Disease can help to reverse age-related impairments in decision making in some older people, a study from researchers at the Wellcome Trust Centre for Neuroimaging has shown.

25 Mar 2013

Botulism Antitoxin Heptavalent gets FDA approval for patients showing signs of botulism

The U.S. Food and Drug Administration announced today that it has approved Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine) to treat patients showing signs of botulism following documented or suspected exposure to botulinum neurotoxin.

25 Mar 2013

Epizyme receives patent for drug candidate for genetically defined type of non-Hodgkin lymphomas

Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it has received a Notice of Issuance from the U.S. Patent and Trademark Office for its patent application entitled "ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS", U.S. Patent No.: 8,410,088.

24 Mar 2013

TOBI Podhaler receives FDA approval for cystic fibrosis patients with Pseudomonas aeruginosa

The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.

24 Mar 2013

Pharmaceutical News

Researchers find HPV vaccination disparities among low-income females

Viewpoints: Rising cost of Tricare; GOP needs to better explain Medicare eligibility age issue; Don't forget adult immunizations

Questions from High Court suggest concerns about 'pay-for-delay' deals

Lundbeck, Otsuka reach agreement to develop and commercialize Lu AE58054

Clinigen announces acquisition of Cardioxane from Novartis

New vaccine proves highly effective against H5N1 virus

Experts to meet in Cape Town to discuss development of vaccines for deadly airborne disease

Supreme Court to hear case about 'pay to delay' deals between generic and branded drug makers

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

arGEN-X advances ARGX-112 into formal preclinical development

Scientists develop new chemo drug that fights cancer without impacting fertility

Japan's MHLW approves XELJANZ for treatment of adults with rheumatoid arthritis

First Edition: March 25, 2013

Actavis settles patent litigation with AstraZeneca over generic version of Crestor

Study shows why certain drugs that interact with serotonin receptors have harmful effects

Anti-inflammatory drug naproxen may exhibit antiviral activity against influenza A virus

Parkinson's Disease drug can help reverse age-related impairments in decision making: Study

Botulism Antitoxin Heptavalent gets FDA approval for patients showing signs of botulism

Epizyme receives patent for drug candidate for genetically defined type of non-Hodgkin lymphomas

TOBI Podhaler receives FDA approval for cystic fibrosis patients with Pseudomonas aeruginosa

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News